GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Pixium Vision SA (OTCPK:PXMVD) » Definitions » Institutional Ownership

Pixium Vision (Pixium Vision) Institutional Ownership : 0.33% (As of Jun. 19, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Pixium Vision Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Pixium Vision's institutional ownership is 0.33%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Pixium Vision's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Pixium Vision's Float Percentage Of Total Shares Outstanding is 0.00%.


Pixium Vision Institutional Ownership Historical Data

The historical data trend for Pixium Vision's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pixium Vision Institutional Ownership Chart

Pixium Vision Historical Data

The historical data trend for Pixium Vision can be seen below:

2023-02-28 2023-03-31 2023-04-30 2023-05-31 2023-06-30 2023-07-31 2023-08-31 2023-09-30 2023-10-31 2023-11-30
Institutional Ownership 0.06 0.06 0.21 0.16 0.47 0.47 0.34 0.01 0.33 0.33

Pixium Vision Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Pixium Vision (Pixium Vision) Business Description

Traded in Other Exchanges
Address
74 rue du Faubourg Saint Antoine, Paris, FRA, 75012
Pixium Vision SA is engaged in the business of developing implantable medical devices to treat blindness resulting from the degeneration of retinal photoreceptor cells.

Pixium Vision (Pixium Vision) Headlines

No Headlines